Halozyme Therapeutics
HALO
#2058
Rank
HK$58.46 B
Marketcap
HK$461.55
Share price
-3.01%
Change (1 day)
50.44%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): HK$3.25 B

According to Halozyme Therapeutics's latest financial reports the company's current earnings (TTM) are HK$3.24 B. In 2023 the company made an earning of HK$2.71 B an increase over its 2022 earnings that were of HK$1.94 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$3.25 B19.99%
2023 HK$2.71 B39.94%
2022 HK$1.94 B0.16%
2021 HK$1.93 B92.2%
2020 HK$1.00 B-278.96%
2019 -HK$0.57 B-9.45%
2018 -HK$0.63 B-229.51%
2017 HK$0.48 B-160.48%
2016 -HK$0.8 B216.03%
2015 -HK$0.26 B-52.86%
2014 -HK$0.54 B-18.09%
2013 -HK$0.66 B55.88%
2012 -HK$0.42 B169.94%
2011 -HK$0.16 B-63.44%
2010 -HK$0.43 B-7.19%
2009 -HK$0.46 B15.91%
2008 -HK$0.4 B83.89%
2007 -HK$0.22 B78.1%
2006 -HK$0.13 B16%
2005 -HK$0.11 B45.24%
2004 -HK$71.25 M682.42%
2003 -HK$9.11 M1659.12%
2002 -HK$0.52 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$0.10 B-96.67%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$70.07 B 2,057.23%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.59 B-118.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$9.45 B-390.85%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$52.61 B 1,519.79%๐Ÿ‡ซ๐Ÿ‡ท France
HK$158.02 B 4,765.06%๐Ÿ‡บ๐Ÿ‡ธ USA